MKS Inc. MKSI
Composite 44/100; the shares have moved about 69% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Balance-sheet strength ranks 26/100 — a moderate mark against it.
Growth ranks 68/100 — a moderate point in its favour. Momentum ranks 52/100 — a slight point in its favour.
Balance-sheet strength ranks 26/100 — a moderate mark against it. Valuation ranks 35/100 — a moderate mark against it. Income ranks 41/100 — a slight mark against it.
What the company does MKS Inc. supplies foundational technology solutions to semiconductor manufacturing, electronics, and specialty industrial applications through three divisions: Vacuum Solutions (pressure/flow control), Photonics Solutions (lasers/optics), and Material Solutions (plating/finishing).
Key financials MKSI reports revenue growth of 15% and EPS growth of 53%, with gross margins at 47% and net margins at 8%. ROE is 13%, ROA 4%, and ROCE 9%. Debt/equity stands at 1.53, net debt/EBITDA at 4.0, and interest coverage at 2.7.
Stock health Momentum is strong over 3m (11%), 6m (24%), and 12m (190%), though down 34% from its 52-week high. Sideravia scores MKSI 48 overall (average quality, rich valuation, positive momentum), with Valuation at the 25th percentile.
Price vs fair value MKSI trades at a PREMIUM of 78% to our fair-value estimate of 64.19 and a discount of 41% to the 12-month target of 412.31. - Surge tied to next-gen chip demand (Zacks, Insider Monkey) - HBM demand tailwinds highlighted (Insider Monkey) - Earnings growth expected next week (Zacks) - Analysts cite mission-critical role in semiconductor supply chain (Insider Monkey)
Looking forward Forward P/E of 10.4 and PEG of 0.02 suggest deep value relative to growth, but high trailing P/E (69) and EV/EBITDA (28.7) temper near-term upside. Momentum remains supportive, yet valuation percentile (25) signals rich pricing.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.